Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Merck says its antiviral medicine met late-stage primary endpoint
Merck says its antiviral medicine met late-stage primary endpoint
Merck says its antiviral medicine met late-stage primary endpoint
Submitted by
admin
on October 19, 2016 - 10:48am
Source:
Marketwatch
News Tags:
Merck
antivirals
clinical trials
letermovir
stem cell transplant
Headline:
Merck says its antiviral medicine met late-stage primary endpoint
Do Not Allow Advertisers to Use My Personal information
